Rowan University: Targeting a Brain Receptor to Alter Opioid Effects
June 30, 2022
June 30, 2022
GLASSBORO, New Jersey, June 30 (TNSres) -- Rowan University issued the following news:
Morphine is the first-line treatment for acute severe pain, but drugs like it pose a serious risk of addiction. Dr. Amanda Fakira, assistant professor in the Department of Biomedical Sciences at Cooper Medical School of Rowan University, is targeting receptors in the brain that can modulate the effects of opioids on the body.
"We're trying to identify targets that would pres . . .
Morphine is the first-line treatment for acute severe pain, but drugs like it pose a serious risk of addiction. Dr. Amanda Fakira, assistant professor in the Department of Biomedical Sciences at Cooper Medical School of Rowan University, is targeting receptors in the brain that can modulate the effects of opioids on the body.
"We're trying to identify targets that would pres . . .